Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALT $11.61 1.3300 +12.94%
PVCT $2.32 0.2100 +9.95%
SRNE $10.55 0.9000 +9.33%
AMBI $6.94 0.5300 +8.27%
CYTR $3.23 0.2300 +7.67%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

INO $2.52 -0.1500 -5.62%
THLD $3.83 -0.1900 -4.73%
INFI $10.15 -0.4500 -4.25%
NYMX $5.04 -0.2199 -4.18%
KPTI $31.09 -1.3100 -4.04%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Physicians’ Education Resource Co-Program Director Honored with Lectureship Award

(Yahoo! Finance) Apr 9, 2014 - The Bonnie J. Addario Lung Cancer Foundation (ALCF) announced today the winner of its 2014 Lectureship Award is Dr. Roy Herbst, a medical oncologist at Yale Cancer Center and distinguished co-director of the International Lung Cancer Congress (ILCC).
read article 

Oncologist Wins National Award

(Huntersville Herald [Huntersville, NC]) Apr 10, 2014 - The Association of Community Cancer Centers awarded John Powderly II with the 2014 David King Community Clinical Scientist Award on April 2 at its national meeting.
read article 

Johns Hopkins Researchers Receive Honors and Awards at the American Association for Cancer Research Annual Meeting

(Johns Hopkins Medicine) Apr 9, 2014 - The following announcements are related to awards that have been presented during the American Association for Cancer Research (AACR) Annual Meeting 2014, held in San Diego April 5-9, to researchers at the Johns Hopkins Kimmel Cancer Center.
read press release 

Celsion Announces ThermoDox HCC Program to Be Discussed at the 2014 European Conference on Interventional Oncology in Berlin, Germany

(MarketWatch) Apr 10, 2014 - Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study.
read article 

Guided Therapeutics Receives May 8th Meeting Date from FDA to Discuss LuViva Advanced Cervical Scan PMA Application

(Yahoo! Finance) Apr 10, 2014 - Guided Therapeutics, Inc. today announced that the company has been given a face-to-face meeting date of May 8, 2014, by the U.S. Food and Drug Administration (FDA), to discuss the company’s response to the September 6, 2013 not-approvable letter that the company received from the agency.
read article 

Hospira Wins UK Case to Overturn Patents on Roche Drug Herceptin

(Reuters) Apr 10, 2014 - Hospira has successfully overturned two patents on Roche's top-selling breast cancer drug Herceptin in Britain, clearing the way for it to launch a cheaper copycat version in the country.
read article 

Aveo to Co-Develop NSCLC Candidate with Biodesix' VeriStrat

(Genetic Engineering News) Apr 10, 2014 - Aveo Oncology and Biodesix said today they will co-develop Aveo’s ficlatuzumab with a Biodesix companion diagnostic already on the market, VeriStrat, to identify patients with advanced non-small cell lung cancer (NSCLC) who would be most likely to benefit from the hepatocyte growth factor (HGF) inhibitory antibody.
read article 

Cuts to NCI’s Budget Threaten the Community Clinical Oncology Program

(ACCCBuzz) Apr 10, 2014 - Due to the Congressional budget-reduction mindset, NCI is woefully underfunded, leading to the National Cancer Institute’s (NCI’s) decision to end funding for federally-funded clinical trials through Community Clinical Oncology Program (CCOP) as of June 1, 2014.
read article 

Newport Doctor Paid $11 Million Says 'Data Dump' Doesn't Tell Whole Story

(Orange County Register) Apr 10, 2014 - When Dr. Minh Nguyen got a phone call from a reporter telling him he’d been paid $11 million from Medicare in 2012, he was shocked.
read article 

COA Issues Statement on Release of Medicare Data

(COA) Apr 10, 2014 - The Community Oncology Alliance (COA) strongly disagrees with the release of physician-specific Medicare reimbursement claims data and the manner in which the Centers for Medicare & Medicaid Services (CMS) released the data.
read press statement  

Excessive Use of Mouthwash Could Increase Risk of Oral Cancer

(Dental Tribune International) Apr 10, 2014 - European researchers found that using mouthwash more than three times a day may contribute to the development of oral cancer.
read article 

Identified Epigenetic Factors Associated with an Increased Risk of Developing Cancer

(IDIBELL [Barcelona, Spain]) Apr 10, 2014 - IDIBELL researchers show that one in four human tumor presents genetic polymorphisms associated with increased risk of cancer that cause an epigenetic change that modifies the expression of neighboring genes. Today, the journal Cell Reports publishes the results of the study.
read press release 

A Bad Penny: Cancer’s Thirst For Copper Can Be Targeted

(Duke Medicine) Apr 9, 2014 - Drugs used to block copper absorption for a rare genetic condition may find an additional use as a treatment for certain types of cancer, researchers at Duke Medicine report.
read press release 

IDIBELL Researchers Describe a New Tumor Suppressor Gene in the Liver

(IDIBELL [Barcelona, Spain]) Apr 9, 2014 - A study by the Bellvitge Biomedical Research Institute (IDIBELL) demonstrated that inhibition of NOX4 in liver tumor cells increases their proliferative capacity and therefore its tumorigenic capacity.
read press release 

TGen Study Identifies Growth Factor Receptors That May Prompt the Spread of Lung Cancer

(TGen) Apr 9, 2014 - Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute (TGen).
read press release 

Moffitt Cancer Center Begins Phase I Clinical Trial of New Immunotherapy

(Moffitt) Apr 9, 2014 - Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design.
read press release 

3D Implantable Marker Reported to Clearly Identify Surgical Area in Breast Cancer Patients

(Reuters) Apr 10, 2014 - The BioZorb™ three-dimensional surgical marker improved the ability of radiation oncologists to target radiation treatment for breast cancer, according to a scientific presentation at the 2014 American Brachytherapy Society (ABS) Annual Meeting.
read article 

Interim Clinical Data for Tocagen's Toca 511 & Toca FC in Patients with High Grade Glioma Presented at American Association of Neurological Surgeons Annual Meeting

(MarketWatch) Apr 10, 2014 - Tocagen Inc. today announced that updated interim clinical data from two ongoing investigational studies of Toca 511 in combination with Toca FC in 68 patients with recurrent high grade glioma were presented at the American Association of Neurological Surgeons (AANS) Annual Meeting in San Francisco.
read article 

Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting

(Benzinga) Apr 10, 2014 - Navidea Biopharmaceuticals, Inc. today announced that collaborators from the University of California, San Francisco (UCSF) presented results at the 2014 AACR conference, highlighting the potential utility of imaging agents derived from Navidea's Manocept™ platform in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma (KS).
read article 

Affimed Therapeutics AG: Affimed Highlights Further Data on AFM13, a Bispecific CD30/CD16A TandAb in Development to Treat Hodgkin Lymphoma, at the 2014 AACR Annual Meeting

(Reuters) Apr 10, 2014 - Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
read article 

Immunotherapy Passes Early Tests in NSCLC

(MedPage Today) Apr 9, 2014 - A cancer immunotherapy passed a key test in patients with lung cancer, as response rates and survival correlated with tumor expression of the drug's target, according to a study reported here.
read article (free registration required) 

High-Fat Diet May Boost Breast Cancer Risk

(U.S. News & World Report/HealthDay News) Apr 9, 2014 - For more than three decades, experts have debated whether eating a high-fat diet increases breast cancer risk.
read article 

Older People with Faster Decline in Memory and Thinking Skills May Have Lower Risk of Cancer Death

(American Academy of Neurology) Apr 9, 2014 - Older people who are starting to have memory and thinking problems, but do not yet have dementia, may have a lower risk of dying from cancer than people who have no memory and thinking problems, according to a new study published in the medical journal Neurology.
read press release 

Chimerix CEO Out in Wake of Josh Hardy Compassionate Use Media Frenzy

(Forbes) Apr 10, 2014 - A month after brokering a new Phase III trial of Chimerix’s investigational antiviral drug, company CEO Kenneth I. Moch has been replaced and will be pursuing other interests.
read article 

ASCO Alarmed about Medicare Payment Data Release

(ASCO) Apr 9, 2014 - The American Society of Clinical Oncology (ASCO) is deeply concerned about today’s release of Medicare physician payment data.
read press statement